Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Advanced Oncotherapy Plc (AVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.75 0.00    0.00%
01/01 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.75 - 1.75
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BD6SX109 
SEDOL:  BD6SX10
Advanced Oncotherapy 1.75 0.00 0.00%

Advanced Oncotherapy Company Profile

 
Read the Advanced Oncotherapy company profile to learn more about the business and the management team. View Advanced Oncotherapy Plc facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

174

Equity Type

ORD

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Contact Information

Address 143 Harley street Ground floor
London, W1G 6BH
United Kingdom
Phone 44 20 3617 8728
Fax -

Top Executives

Name Age Since Title
Michael Jeffrey Sinclair 81 2006 Executive Chairman
Enrico Vanni 73 2013 Independent Non-Executive Director
Margaret F. Spittle - - Member of Medical Advisory Board
Nicolas Serandour 49 2014 CEO & Executive Director
Michael Bradfield 74 2013 Independent Non-Executive Director
Piers Nicholas Plowman 74 2017 Independent Chairman of Medical Advisory Board & Non-Executive Director
Jay S. Loeffler - 2013 Member of Medical Advisory Board
Stephen Myers 77 2015 Executive Director
Ugo Amaldi - - Member of Medical Advisory Board
Euan S. Thomson 61 2014 Member of Medical Advisory Board
Hans von Celsing 74 2017 Senior Independent Director
Renhua Zhang 57 2018 Independent Non-Executive Director
Lori Jo Cross 64 2020 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVO Price Commentary

Write your thoughts about Advanced Oncotherapy Plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email